HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts.

Abstract
We have compared the effects of a general matrix metalloproteinase (MMP) inhibitor (CT435) with those of a concentration-dependent specific gelatinase inhibitor (CT543; Ki < 20 nM) on bone resorption in vitro. The test systems consisted of measuring: (i) the release of 45Ca2+ from prelabelled mouse calvarial explants; (ii) the release of 45Ca2+ from prelabelled osteoid-free calvarial explants co-cultured with purified chicken osteoclasts; and (iii) lacunar resorption by isolated rat osteoclasts cultured on ivory slices. Both CT435 and CT543 dose-dependently inhibited the release of 45Ca2+ from neonatal calvarial bones stimulated by either parathyroid hormone or 1,25-dihydroxyvitamin D3. Moreover, CT543 produced a 40% inhibition at a concentration (10(-8) M) selective for the inhibition of human gelatinases A and B. CT435 (10(-5) M) and CT543 (10(-5) M) partially inhibited the release of 45Ca2+ from osteoid-free calvarial explants by chicken osteoclasts with a maximum of approximately 25% for unstimulated cultures, and approximately 36% for cultures stimulated by interleukin-1 alpha (IL-1 alpha; 10(-10) M). Neither inhibitor prevented lacunar resorption on ivory by unstimulated rat osteoclasts, but the compounds produced a partial reduction in both the number and total surface area of lacunae in IL-1 alpha-stimulated cultures, with maximal action at 10(-5) M. Neither of the inhibitors affected protein or DNA synthesis, nor the IL-1 alpha-stimulated secretion of the lysosomal enzyme beta-glucuronidase. Immunocytochemistry demonstrated that isolated rabbit osteoclasts constitutively expressed gelatinase A and synthesized gelatinase B, collagenase and stromelysin, as well as the tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) following IL-1 alpha stimulation. These experiments have shown that in addition to collagenase, gelatinases A and B are likely to play a significant role in bone resorption. They further suggest that MMPs produced by osteoclasts are released into the sub-osteoclastic resorption zone where they participate in bone collagen degradation.
AuthorsP A Hill, G Murphy, A J Docherty, R M Hembry, T A Millican, J J Reynolds, M C Meikle
JournalJournal of cell science (J Cell Sci) Vol. 107 ( Pt 11) Pg. 3055-64 (Nov 1994) ISSN: 0021-9533 [Print] England
PMID7699005 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CT 435
  • CT 543
  • Glycoproteins
  • Morpholines
  • Phenethylamines
  • Tissue Inhibitor of Metalloproteinases
  • Gelatinases
  • Metalloendopeptidases
Topics
  • Animals
  • Bone Resorption (etiology, metabolism)
  • Cells, Cultured
  • Chickens
  • Gelatinases (antagonists & inhibitors)
  • Glycoproteins (metabolism)
  • Immunohistochemistry
  • In Vitro Techniques
  • Metalloendopeptidases (antagonists & inhibitors, metabolism)
  • Mice
  • Morpholines (pharmacology)
  • Osteoclasts (drug effects, metabolism)
  • Phenethylamines (pharmacology)
  • Rats
  • Rats, Wistar
  • Tissue Inhibitor of Metalloproteinases

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: